Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
OtherPractice

Anti-CCP: a truly helpful rheumatoid arthritis test?

Emélie Braschi, Kam Shojania and G. Michael Allan
Canadian Family Physician March 2016, 62 (3) 234;
Emélie Braschi
Family medicine resident at McGill University in Montreal, Que.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kam Shojania
Clinical Professor and Head of the Division of Rheumatology at the University of British Columbia in Vancouver.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Michael Allan
Professor and Director of Evidence-Based Medicine in the Department of Family Medicine at the University of Alberta in Edmonton.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Clinical question

For adult rheumatoid arthritis (RA), what is the diagnostic usefulness of anticyclic citrullinated protein antibodies (anti-CCP)?

Bottom line

With a specificity of about 96% and a positive likelihood ratio of about 14, anti-CCP assists with the diagnosis of RA. It is present in only a quarter to half of patients before or at diagnosis, so a negative result does not rule out RA. It can also predict aggressive joint erosion.

Evidence

  • In 7 systematic reviews1–7 of anti-CCP in adult RA, with 27 to 151 observational studies, pooled results revealed the following:

    • -Sensitivity and specificity2–4,7 were 53% to 71% and 95% to 96%, respectively.

    • -Positive likelihood ratios were 12.5 to 15.9 and negative likelihood ratios were 0.36 to 0.42.3,4

    • -Focusing on higher-level studies with undifferentiated arthritis, the sensitivity was generally lower (about 54%) but the specificity was similar.4

  • A positive anti-CCP result means RA is likely but a negative result does not rule out RA.

  • Concerns include the following (although study quality did not seem to affect findings7):

    • -Few studies were well designed, ie, had cohorts of patients with early stage, undifferentiated RA with long-term follow-up by blinded study personnel.4

    • -There was heterogeneity in control populations,4 study designs,4 test cutoffs,2,6 and laboratory standards.2,6

Context

  • A positive anti-CCP result also predicts joint erosion in RA (odds ratio 4.4; 95% CI 3.6 to 5.3).8

  • Anti-CCP is present in 23% of patients with early stage RA, in about 50% of patients at diagnosis, and in about 53% to 70% of patients 2 years after diagnosis.2

  • Anti-CCP occurs in 1.5% or less of healthy populations and in 10% or less of those with other rheumatic disease, except palindromic rheumatism, in which the occurrence is similar to RA.2 Values might be higher in those with erosive joint disease.9

  • Rheumatoid factor has a similar sensitivity but worse specificity.3 Specificities of anti-CCP and rheumatoid factor are 95% and 85%, respectively.

    • -Positive likelihood ratios are 12.5 and 4.9, respectively.

    • -A positive anti-CCP result is more reliable than a positive rheumatoid factor result for diagnosing RA.

  • Diagnostic criteria for RA include joint involvement, acute-phase reactants, and the serology markers anti-CCP and rheumatoid factor.10

Implementation

Some clinical features might be particularly helpful when considering RA. First, confirm a history of joint pain with morning stiffness of longer than 1 hour that improves with activity. Second, demonstrate joint tenderness at the metacarpophalangeal joints on hyperextension or stressing the wrists at full flexion or by squeezing the forefoot. Try it on yourself to see how hard to press—it should not hurt! If these maneuvers are painful, the patient could have RA. Check for anti-CCP—a positive anti-CCP result makes RA very likely but a negative result is of little help. Handouts for newly diagnosed patients are available.11

Notes

Tools for Practice articles in Canadian Family Physician (CFP) are adapted from articles published on the Alberta College of Family Physicians (ACFP) website, summarizing medical evidence with a focus on topical issues and practice-modifying information. The ACFP summaries and the series in CFP are coordinated by Dr G. Michael Allan, and the summaries are co-authored by at least 1 practising family physician and are peer reviewed. Feedback is welcome and can be sent to toolsforpractice{at}cfpc.ca. Archived articles are available on the ACFP website: www.acfp.ca.

Footnotes

  • The opinions expressed in Tools for Practice articles are those of the authors and do not necessarily mirror the perspective and policy of the Alberta College of Family Physicians.

  • ↵Competing interests: Dr Shojania has consulted for and has stock options with Augurex.

  • Copyright© the College of Family Physicians of Canada

References

  1. 1.↵
    1. Riedemann JP,
    2. Muñoz S,
    3. Kavanaugh A
    . The use of second generation anti-CCP antibody (anti-CCP2) testing in rheumatoid arthritis—a systematic review. Clin Exp Rheumatol 2005;23(5 Suppl 39):S69-76.
    OpenUrlPubMed
  2. 2.↵
    1. Avouac J,
    2. Gossec L,
    3. Dougados M
    . Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2006;65(7):845-51.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Nishimura K,
    2. Sugiyama D,
    3. Kogata Y,
    4. Tsuji G,
    5. Nakazawa T,
    6. Kawano S,
    7. et al
    . Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007;146(11):797-808.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Whiting PF,
    2. Smidt N,
    3. Sterne JA,
    4. Harbord R,
    5. Burton A,
    6. Burke M,
    7. et al
    . Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosing rheumatoid arthritis. Ann Intern Med 2010;152(7):456-64, W155-66.
    OpenUrlCrossRefPubMed
  5. 5.
    1. Schoels M,
    2. Bombardier C,
    3. Aletaha D
    . Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic review. J Rheumatol Suppl 2011;87:20-5.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Taylor P,
    2. Gartemann J,
    3. Hsieh J,
    4. Creeden J
    . A systematic review of serum biomarkers anti-cyclic citrullinated peptide and rheumatoid factor as tests for rheumatoid arthritis. Autoimmune Dis 2011;2011:815038. Erratum in: Autoimmune Dis 2012;2012:734069.
    OpenUrlPubMed
  7. 7.↵
    1. Zintzaras E,
    2. Papathanasiou AA,
    3. Ziogas DC,
    4. Voulgarelis M
    . The reporting quality of studies investigating the diagnostic accuracy of anti-CCP antibody in rheumatoid arthritis and its impact on diagnostic estimates. BMC Musculoskelet Disord 2012;13:113.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Jilani AA,
    2. Mackworth-Young CG
    . The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis. Int J Rheumatol 2015;2015:728610.
    OpenUrlPubMed
  9. 9.↵
    1. Budhram A,
    2. Chu R,
    3. Rusta-Sallehy S,
    4. Ioannidis G,
    5. Denburg JA,
    6. Adachi JD,
    7. et al
    . Anti-cyclic citrullinated peptide antibody as a marker of erosive arthritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Lupus 2014;23(11):1156-63.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Aletaha D,
    2. Neogi T,
    3. Silman AJ,
    4. Funovits J,
    5. Felson DT,
    6. Bingham CO 3rd.,
    7. et al
    . 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62(9):2569-81.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Rheumatoid arthritis: a guide for adult patients. Vancouver, BC: British Columbia Ministry of Health, British Columbia Medical Association; 2012.
PreviousNext
Back to top

In this issue

Canadian Family Physician: 62 (3)
Canadian Family Physician
Vol. 62, Issue 3
1 Mar 2016
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Anti-CCP: a truly helpful rheumatoid arthritis test?
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Anti-CCP: a truly helpful rheumatoid arthritis test?
Emélie Braschi, Kam Shojania, G. Michael Allan
Canadian Family Physician Mar 2016, 62 (3) 234;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Anti-CCP: a truly helpful rheumatoid arthritis test?
Emélie Braschi, Kam Shojania, G. Michael Allan
Canadian Family Physician Mar 2016, 62 (3) 234;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Clinical question
    • Bottom line
    • Evidence
    • Context
    • Implementation
    • Notes
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Citrullination of a phage displayed human peptidome library reveals the fine specificities of rheumatoid arthritis-associated autoantibodies
  • Individuals at risk for developing rheumatoid arthritis harbor differential intestinal bacteriophage communities with distinct metabolic potential
  • Impending radiographic erosive progression over the following year in a cohort of consecutive patients with inflammatory polyarthritis: prediction by serum biomarkers
  • Google Scholar

More in this TOC Section

Practice

  • Is 45 the new 50 in colorectal cancer screening?
  • Approach to diagnosis and management of childhood attention deficit hyperactivity disorder
  • Determining if and how older patients can safely stay at home with additional services
Show more Practice

Tools for Practice

  • Bronchodilators or inhaled corticosteroids for postinfectious cough
  • Intrauterine devices for menorrhagia
  • Topical treatments for anal fissure
Show more Tools for Practice

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2023 by The College of Family Physicians of Canada

Powered by HighWire